Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2025-04-25 00:00:00 ET · period of report 2025-03-24 · accession 0001140361-25-015712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-25 | 2025-03-24+ | GYRE | Ye Weiguo | COO | M - OptEx | $0.75 | +650.0K | 300.0K | New | +$487.5K |
| DM | 2025-04-25 | 2025-03-24+ | GYRE | Ye Weiguo | COO | M - OptEx | $0.00 | -650.0K | 1.17M | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-26 | M | A | 200,000 | $0.75 | 500,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-27 | M | A | 150,000 | $0.75 | 650,000 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-24 | M | A | 300,000 | $0.75 | 300,000 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-03-24 | M | D | 300,000 | $0.00 | 1,365,115 | D | $0.75 · — to 2030-10-31 | 300,000 Common Stock | (F1) These options are vested in full. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-03-27 | M | D | 150,000 | $0.00 | 1,015,115 | D | $0.75 · — to 2030-10-31 | 150,000 Common Stock | (F1) These options are vested in full. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-03-26 | M | D | 200,000 | $0.00 | 1,165,115 | D | $0.75 · — to 2030-10-31 | 200,000 Common Stock | (F1) These options are vested in full. |